XML 78 R57.htm IDEA: XBRL DOCUMENT v3.24.3
BUSINESS COMBINATIONS - Schedule of Fair Values of Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Millions
Aug. 19, 2024
Aug. 18, 2024
Jul. 22, 2024
Sep. 30, 2024
Dec. 31, 2023
Business Acquisition [Line Items]          
Goodwill       $ 1,605.3 $ 1,145.1
Endotronix, Inc          
Business Acquisition [Line Items]          
Cash consideration paid at closing $ 650.3 $ 60.0      
Settlement of pre-existing relationships 53.1        
Fair value of previously held equity interest 94.6 $ 10.0      
Fair value of contingent consideration 2.0        
Total purchase price 800.0        
Less: cash acquired (1.2)        
Total purchase price, net of cash acquired 798.8        
Current assets 7.7        
Property and equipment, net 12.6        
Goodwill 412.0        
Operating lease right-of-use assets 9.9        
Other assets 0.7        
Liabilities assumed (26.3)        
Deferred tax liabilities (70.6)        
Net assets acquired 800.0        
Endotronix, Inc | In-process research and development          
Business Acquisition [Line Items]          
Intangibles 69.0        
Endotronix, Inc | Developed technology          
Business Acquisition [Line Items]          
Intangibles $ 385.0        
JC Medical, Inc          
Business Acquisition [Line Items]          
Cash consideration paid at closing     $ 114.8    
Fair value of contingent consideration     1.8    
Total purchase price     116.6    
Less: cash acquired     (0.3)    
Total purchase price, net of cash acquired     116.3    
Current assets     0.3    
Property and equipment, net     0.3    
Goodwill     46.9    
Current liabilities assumed     (1.0)    
Deferred tax liabilities     (16.5)    
Net assets acquired     116.6    
JC Medical, Inc | In-process research and development          
Business Acquisition [Line Items]          
Intangibles     $ 86.6